Medication Minute: Sipuleucel-T (Provenge): Immunotherapy for Metastatic Prostate Cancer

Medication Minute: Sipuleucel-T (Provenge): Immunotherapy for Metastatic Prostate Cancer


Identification: unj_ma12_08
Issue: March-April 2012
Volume: Volume 32 Number 2


Credits

Credits: None available.